LNSP Bulletin No. 8, October-December 2018
- Five hospitals were named sentinel sites for antimicrobial resistance surveillance and their technicians trained at the LNSP in December 2018.
- A national action plan against antimicrobial resistance was drafted with PAHO and WHO, covering human health, animal health, agriculture, food and the environment.
- The GHESKIO pilot study found rifampicin resistance in 81 of 3,028 patients enrolled, 2.6 per cent, with at least half of the multidrug resistant cases arising as primary resistance.
- A count to October 2018 found 1,075 laboratories in the ten health departments: 379 public, 501 private and 195 mixed.
- The logistics unit moved 90,112 specimens and transmitted 89,106 results in fiscal year 2017/2018, of which 75,287 specimens were for viral load.
The LNSP set up a sentinel surveillance network for antimicrobial resistance at five hospitals: the Hôpital Universitaire Justinien, the Hôpital Saint Nicolas, the Hôpital Albert Schweitzer, the Hôpital Universitaire la Paix and the Hôpital Immaculée Conception des Cayes. Technicians from those sites trained at the LNSP in December 2018, and a national action plan against antimicrobial resistance was drafted with PAHO and WHO covering human health, animal health, agriculture, food and the environment. The issue reports preliminary results of the GHESKIO pilot study on the molecular epidemiology of multidrug resistant tuberculosis, presented on 15 October 2018: 81 of 3,028 patients enrolled showed resistance to rifampicin, 2.6 per cent, and at least half of the multidrug resistant cases were primary resistance. A count to October 2018 found 1,075 laboratories in the ten health departments. The PAHO and WHO evaluation of influenza molecular diagnosis scored the molecular biology service 95 per cent.
How to cite
National Public Health Laboratory (LNSP); Ministry of Public Health and Population (MSPP), LNSP Bulletin No. 8, October-December 2018, https://mspp.gouv.ht/publications